Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 1, 2008

View Archived Issues

Ascorbate demonstrates anticancer activity in vitro and in vivo

IL-21 immunologically active in patients with metastatic melanoma, renal cell carcinoma

Johnson & Johnson research into tryptase inhibitors continues with new compounds

PEG coating allows nanoparticles to penetrate the mucus barrier

Immunoglobulin intravenous appears safe over 48 weeks in CIDP patients

S-Methylisothiourea reduces cerebral ischemia damage in vivo

QseC signaling inhibition with LED-209 blocks bacterial vigilance

Novel p38 MAP kinase inhibitors synthesized at Palau Pharma

Growth hormone secretagogue BMS-606056 displays promising preclinical characteristics

Transgene and Roche modify clinical development program for TG-4001/R-3484

Eisai offers Q1 overview

Recent sanofi-aventis patent discloses new analgesic agents

Novel therapeutic agents for glaucoma reported in recent Allergan patents

Arpida submits NDS for intravenous iclaprim in Canada

Recent patents disclose novel antiinfective agents

Overall survival results reported in Erbitux phase III lung cancer study

Shionogi acquires U.S.-based Sciele Pharma

sanofi-aventis acquires Symbion

EMEA approves Intelence for the treatment of HIV

Taxotere Injection approved in Japan for prostate cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...